Barnett, Anthony H (2011) New treatments for type 2 diabetes in the UK - an evolving landscape. Primary care diabetes, 5 (1). pp. 1-7. ISSN 1878-0210. This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their HEFT Athens login IdsFull text not available from this repository.
New classes of treatments for type 2 diabetes have been developed recently and are now available in the UK. This review aims to summarise key clinical efficacy, tolerability and safety data for these agents, including liraglutide, which has received preliminary review by the National Institute for Clinical Excellence (NICE) and was launched in the UK in 2009.
|Additional Information:||This article is accessible to all HEFT staff and students via NHS Evidence www.evidence.nhs.uk by using their HEFT Athens login Ids|
|Subjects:||WK Endocrine system. Endocrinology|
|Divisions:||Ambulatory Care > Diabetes|
|Depositing User:||Mr Philip O'Reilly|
|Date Deposited:||26 Jun 2014 14:26|
|Last Modified:||26 Jun 2014 14:26|
Actions (login required)